|
AGREE II |
Appraisal of Guidelines for Research and Evaluation II |
|
AUS |
Atypia of Undetermined Significance. |
|
CEUS |
Contrast-Enhanced Ultrasound. |
|
CNB |
Core-Needle Biopsy. |
|
CT |
Computed Tomography. |
|
EA |
Ethanol Ablation. |
|
FNA |
Fine Needle Aspiration. |
|
FNAB |
Fine Needle Aspiration Biopsy. |
|
GDG |
Guideline Development Group. |
|
GRADE |
Grade of Recommendations, Assessment, Development and Evaluation. |
|
MEA |
Multiple Endocrine Anaplasia. |
|
MEN2 |
Multiple Endocrine Neoplasia 2 |
|
MIT |
Minimally Invasive Techniques. |
|
MRI |
Magnetic Resonance Imaging |
|
PRO |
Patient-Reported Outcome. |
|
RAI |
Radioactive Iodine. |
|
ROM |
Risk of Malignancy |
|
RSS |
Risk Stratification System. |
|
TA |
Thermal Ablation. |
|
TBSRTC |
Bethesda System for Reporting Thyroid Cytopathology. |
|
EU-TIRADS |
European Thyroid Imaging and Reporting Data System. |
|
US |
Ultrasound. |
|
TSH |
Thyroid-Stimulating Hormone. |